← The Wire
DTILNasdaq
PRECISION BIOSCIENCES INC
Biological Products, (No Diagnostic Substances) · DE · CIK 1357874
Precision BioSciences develops in vivo gene editing therapies using its proprietary ARCUS platform for sophisticated gene edits
red 8-K · 90d
$157M
Market cap
$7.92
Last close
+8.6%
1D
+11.9%
5D
775K
Volume
Price · last 39 sessions+3.8%
May 4L $6.04 · H $8.34Jun 29
194
Total filings
Jun 16, 2026
Last filing
05/21
Fiscal year end
10-Q10-QMay 5, 202610-Q10-QNov 3, 202510-Q10-QAug 7, 202510-Q10-QMay 15, 202510-Q10-QNov 4, 202410-Q10-QAug 1, 202410-Q10-QMay 13, 202410-Q10-QNov 7, 202310-Q10-QAug 4, 202310-Q10-QMay 9, 202310-Q10-QNov 8, 202210-QQ2 2022 10-QAug 8, 202210-QQ3 2022 10-QMay 9, 202210-QQ3'21 10-QNov 10, 202110-Q10-QAug 12, 202110-QQ1'21 10-QMay 13, 202110-Q10-QNov 10, 202010-Q10-QAug 13, 202010-Q10-QMay 15, 202010-Q10-QNov 12, 201910-Q10-QAug 14, 201910-Q10-QApr 29, 2019
Insider Activity
◆ Cluster Buy · 3 insidersIn the 90 days to Feb 18, 2026: 3 insiders bought $34K · 4 sold $431K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 18, 2026 | Amoroso MichaelPresident and CEO | Sell | 20,559 | $3.84 | $79K |
| Feb 18, 2026 | Kelly John AlexanderChief Financial Officer | Sell | 8,149 | $3.84 | $31K |
| Feb 18, 2026 | Scimeca DarioGeneral Counsel and Secretary | Sell | 4,925 | $3.84 | $19K |
| Feb 18, 2026 | Smith J. JeffersonChief Research Officer | Sell | 4,925 | $3.84 | $19K |
| Jan 22, 2026 | Amoroso MichaelPresident and CEO | Sell | 34,799 | $4.17 | $145K |
| Jan 21, 2026 | Kelly John AlexanderChief Financial Officer | Sell | 15,213 | $4.03 | $61K |
| Jan 21, 2026 | Smith J. JeffersonChief Research Officer | Sell | 10,200 | $4.03 | $41K |
| Jan 21, 2026 | Scimeca DarioGeneral Counsel and Secretary | Sell | 8,854 | $4.03 | $36K |
| Dec 16, 2025 | Germano Geno JDirector | Buy | 3,000 | $4.72 | $14K |
| Dec 16, 2025 | Frankel StanleyDirector | Buy | 2,700 | $4.70 | $13K |
| Dec 15, 2025 | Brown MelindaDirector | Buy | 1,381 | $4.97 | $7K |
| Nov 3, 2025 | Amoroso MichaelPresident and CEO | Sell | 3,409 | $6.49 | $22K |
| Nov 3, 2025 | Kelly John AlexanderChief Financial Officer | Sell | 1,303 | $6.49 | $8K |
| Nov 3, 2025 | Scimeca DarioGeneral Counsel and Secretary | Sell | 665 | $6.49 | $4K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance